Category

• Pipeline2
• Products1

Organizations

• Bausch + Lomb64
• Eyes On Eyecare42
• Alcon, Inc.41
• American Optometric Association34
• Harrow26
• Glaukos25
• Regeneron21
• Aldeyra Therapeutics20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Choroidal Melanoma3
• Clinical Trials3
• Injections1

• Organizations: Aura Biosciences✕

Clear all

Pipeline

Aura Biosciences reports positive end-of-study phase 2 data for choroidal melanoma

Company plans to advance bel-sar clinical program with global phase 3 CoMpass trial.

Pipeline

Aura Biosciences reports positive data from bel-sar trial on choroidal melanoma

Favorable interim results support plans for a global phase 3 trial.

Products

Aura begins startup design for phase 3 trial of bel-sar for early-stage CM

Aura Biosciences Inc. is finalizing the design for the global phase 3 trial of belzupacap sarotalocan (AU-011), a novel therapy for the treatment of early-stage choroidal melanoma. (via.)